Archive | March, 2011

SCMP Group Limited Reports Five-Fold Increase in Net Profit From Normal Business Operations

SCMP Group Limited Reports Five-Fold Increase in Net Profit From Normal Business Operations

SCMP Group Limited (SCMP Group) today announced the audited final results for the year ended December 31, 2010.

Net profit attributable to shareholders for the year 2010 was $294 million, which more than doubled last year’s profit of $138 million. Excluding the impact of property revaluation gain, net profit from normal business operations recorded a five-fold increase from $26 million in 2009 to $128 million in 2010. The increase was led by a significant growth in the newspaper publishing business. Revenue for the Group rose 19% to $881 million. Revenues from both display advertising and recruitment services increased significantly in line with the upturn of the local economy and with management’s efforts to drive revenue. Operating costs before depreciation and amortisation showed a moderate growth of 4% mainly due to market driven staff cost increase, partly offset by savings in newsprint, rental and advertising & promotion expenses. The SCMP Group declared a final dividend of HK4 cents per share, together with HK2 cents interim dividend paid, full year dividend will amount to HK6 cents per share.

“Our recovery in 2010 was the result of a combination of diligent efforts to rein in costs and seek new business opportunities, as well as a healthy sustained recovery in the advertising, IPO and recruitment markets,” said the Managing Director & CEO Ms. Kuok Hui Kwong.

Revenue from advertising and marketing services increased 25%, mainly due to a higher volume of display advertising in the newspaper segment, followed by notices advertisement, glossy magazines, customized publishing and special execution services.

Recruitment revenue increased 43%. Print revenue rebounded strongly with higher advertising volumes in both Classified Post and Jiu Jik. Online recruitment revenue also recorded significant growth in 2010.

Combined full year readership figures for 2010 for South China Morning PostSunday Morning Postand print and online editions showed a 3% increase to 388,000.

“The SCMP Group has made substantial progress in strengthening our financial performance, as well as paving the way for future growth with a more robust portfolio of products,” Ms Kuok said.

“Our efforts in 2010 were focused on building longer term revenue. Our aim is to continue to strengthen our brands, our print and digital products, our editorial content and our portfolio of services to deliver the best value for both our readers and our advertising clients.”

About The SCMP Group
SCMP Group Limited (HKSE: 583) is a leading newspaper and magazine publisher in Asia. Its flagship publication, South China Morning Post, is Hong Kong’s world renowned English language newspaper and has the city’s most affluent and influential readership. First published in 1903, the newspaper has developed an enviable reputation for authoritative, influential and independent reporting on Hong Kong, China and the rest of Asia. Available in print, iPad and online through scmp.com and e-reader editions, South China Morning Post reaches a global audience with daily breaking news, insightful analysis and opinion, multimedia articles and interactive forums. Striving to maintain the highest standards among the world’s quality newspapers, the South China Morning Post receives constant international recognition. It received 60 awards in 2010 for excellence in editorial, marketing and technical capability. Other publication titles of the Group include the Sunday Morning Post, Classified Post, JiuJik, Fuel, and the Chinese editions of Cosmopolitan, CosmoGirl! and Harper’s Bazaar. For more information, please visit us at www.scmpgroup.com.

Posted in Press ReleasesComments (0)

First China Pharma Announces $3 Million Capital Raise

First China Pharma Announces $3 Million Capital Raise

First China Pharmaceutical Group, Inc.(OTCBB: FCPG) (“First China” or the “Company”) is pleased to announce that a US$3,000,000 capital financing is well under way with US$2.7 million recently closed.

The current financing comes on the heels of a previous US$500,000 raise bringing the total funding to US$3.5 million. The latest capital raise is exclusively led by Mark I. Lev of Wellfleet Partners, Inc. a New York based investment and merchant banking firm. The raise includes three lead institutional investors including Cedarview Capital and it is anticipated that the balance of the financing will be completed by month end.

The capital proceeds are slated to expand sales and customer relationship teams as well as to significantly increase product lines to over 25,000 items. The funding will also enable the company to strengthen its finance department in anticipation of significant growth for fiscal 2011.

The acquisition of Guangdong based pharmaceutical distributor, Shenzhen Ming He Tang, remains a top priority for the company with high level discussions planned for the near future

The Southern Medical Economic Institute under the State Food and Drug Administration, projects that the pharmaceutical market in China will grow 24% in 2011. First China is positioning itself to take advantage of this growth as well as to exploit the move to an increase in electronic ordering of drugs as recently mandated by the Chinese government.

First China continues its efforts to identify and ensure compliance with favorable government initiatives in the drug distribution sector, many of which are tied to the loosening of economic regulations which have opened the door to foreign investment in the healthcare sector. As a result of these enterprises the overall market sector outlook is exceptionally positive and First China is now reaching a level where momentum is propelling the Company towards exponential growth in the months ahead.

Details of the company’s business, finances, appointments and agreements can be found as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (“SEC”) EDGAR database.

About Wellfleet Partners, Inc.
Founded by Mark I. Lev in early 1998, Wellfleet Partners Inc. (Wellfleet) is a boutique investment and merchant banking, venture capital, financial services, and consulting firm. Wellfleet’s emphasis is to engage in a wide variety of corporate finance, venture capital, management consulting, and corporate investment banking related activities to a broad range of public and private emerging small to medium size growth companies. In addition, through subsidiaries and/or affiliates, Wellfleet offers financial, brokerage, and money management services through Sandgrain Securities, Inc. Wellfleet maintains strategic partnerships and offices in London, England; Ra’anana and Tel Aviv, Israel; Dublin, Ireland; Miami and Fort Lauderdale, Florida; Northern (Palo Alto) and Southern (Lost Angeles and San Diego) California; and in conjunction with MRM Finance LLC, jointly opened an office in Beijing, China in 2008. Wellfleet renders all of its fund raising and investment banking related activities through Sandgrain Securities, Inc., a registered FINRA broker-dealer primarily headquartered in New York. For more information, please go to www.wellfleetpartners.com.

About First China Pharmaceutical Group, Inc. (OTCBB: FCPG)
First China Pharmaceutical Group, Inc. engages in the drug logistics and distribution business through drug stores, medical clinics, and hospitals in the People’s Republic of China. It also involves in the wholesale distribution of medicine products, chemical agents, antibiotics, biochemistry drugs, and biological preparations. The company distributes approximately 5,000 drugs, including 1,000 over-the-counter drugs, 1,000 prescription drugs, 2,000 prepared Chinese medicines, and 1,000 supplements. First China Pharmaceutical Group distributes its products through the Internet; sub-distributors; and hospitals, clinics, pharmacies, and other medical institutions, as well as through its drug stores. The company was formerly known as E-Dispatch Inc. and changed its name to First China Pharmaceutical Group, Inc. in May 2010. First China Pharmaceutical Group, Inc. was founded in 2002 and is headquartered in Kunming City, the People’s Republic of China. For more information visit: www.firstchinapharma.com

Notice Regarding Forward-Looking Statements
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, regulatory incentives, the development of new business opportunities, and projected costs, revenue, profits and results operations. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Posted in Press ReleasesComments (0)

Deputy Minister of Ministry of Land and Resources of China Affirms Achievements of Chinese Mining Companies in Presentation at PDAC in Toronto

Deputy Minister of Ministry of Land and Resources of China Affirms Achievements of Chinese Mining Companies in Presentation at PDAC in Toronto

China Gold International Resources Corp. Ltd. (TSX:CGG)(HK:2099) (“China Gold International” or the “Company”) is pleased to report that the Deputy Minister of Ministry of Land and Resources of the People’s Republic of China (the “Ministry), met with the Company during the 2011 Prospectors and Developers Association of Canada (PDAC) mining conference in Toronto.

Deputy Minister Wang acknowledged the growing international presence and success of Chinese mining enterprises affirming also the Green Mine concept ,and singled out China Gold International in particular in this regard. Mr. Song Xin, the CEO of China Gold International, expressed thanks to Deputy Minister Wang. Mr. Song Xin also commented that the Company had benefitted from the full support of the Chinese government and the Ministry through China National Gold Group (CNG), the Company’s largest shareholder, and he expressed thanks again to the support given by the Ministry on behalf of both companies.

The Company continues to expand its international presence, and at PDAC met and built new relationships with a number of targeted parties with leadership roles in the mining and the financial industry. China Gold International is investigating business development opportunities globally in furtherance of its mandate as the flagship international mineral company of the China National Gold Group.

About China Gold International Resources Corp. Ltd.:

China Gold International Resources Corp. Ltd. is a mining company whose principal properties are the CSH gold mine and the Jiama copper poly-metallic Mine. The Company’s shares are listed on the TSX under the symbol “CGG” and on the HKSE under stock code “2099″. China National Gold Group Corporation, a Chinese state-owned enterprise owns approximately 39% of China Gold International Resources Corp. Ltd.’s shares.

Forward-looking statements

Certain statements made herein, and other statements relating to matters that are not historical facts and statements of our beliefs, intentions and expectations about developments, results and events which will or may occur in the future, constitute “forward-looking information” within the meaning of applicable securities legislation. Forward-looking information and statements are typically identified by words such as “anticipate”, “could”, “should”, “expect”, “seek”, “may”, “intend”, “likely”, “plan”, “estimate”, “will”, “believe” and similar expressions suggesting future outcomes or statements regarding an outlook. All such forward-looking information and statements are based on certain assumptions and analysis made by China Gold International Resources Corp. Ltd.’s management in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. These statements, however, are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information or statements. Important factors that could cause actual results to differ from these forward-looking statements include those described under the heading “Risks and Uncertainties” elsewhere in the Company’s MD&A filed at www.SEDAR.com. The reader is cautioned not to place undue reliance on forward-looking information or statements. Except as required by law the Company does not assume the obligation to revise or update these forward looking statements after the date of this document or to revise them to reflect the occurrence of future, unanticipated events.

Posted in Press ReleasesComments (0)

China Vesting Upgrades China Direct Industries to the China Dragon Undervalued Index

China Vesting Upgrades China Direct Industries to the China Dragon Undervalued Index

China Vesting, a leading investment newsletter dedicated to Chinese public companies listed in the United States, today announced that is has reconstituted its index of U.S.-listed Chinese Public Companies. Florida-based China Direct Industries (NASDAQ: CDII), a leader in the production and distribution of magnesium, and distributor of basic materials in the People’s Republic of China, was added to the China Dragon Undervalued Index.

China Direct operates two main segments, Magnesium and Basic Materials. The Magnesium segment produces and distributes various magnesium products, such as magnesium ingots, magnesium powders, magnesium alloys, various grades of magnesium slabs, and magnesium scraps. The Basic Materials segment involves in the sale and distribution of industrial grade synthetic chemicals, steel and non-ferrous metals. Further, China Direct Industries, Inc. offers consulting services to United States and Chinese companies.

China Direct Industries has given public guidance estimates for fiscal 2011 with revenue of $180 million and net income of $12 million. China Vesting added CDII to its Dragon Undervalued Index based on the company being one of the only Chinese Companies based in America with senior management that are American Citizens, who live and reside in the U.S. and thus must obey American laws and standards.

Members of Dragon Undervalued Index represent deeply undervalued Chinese companies trading on U.S. exchanges. There are many parameters China Vesting uses to decide what companies are eligible to be classified as a Dragon. The most important being: A member company must possess a market value that is less than comparables. The most common metric China Vesting will use is price to earnings (P/E) and enterprise value to earnings (EV/E). The market value must be significantly less to the point where the market value of the public company is less than or equal to what the company is worth as a private company. To read the full report regarding China Direct Industries inclusion into the China Dragon Undervalued Index, please navigate to: http://www.chinavesting.com/top-china-stock-pick-articles/The-Best-Chinese-Company-In-America-2010-03-22.htm

China Vesting determines membership for its indexes primarily by objective, market-capitalization rankings and style attributes.

Total returns data for the China 100 Index and other China Vesting Indexes are available athttp://www.chinavesting.com

About China Vesting:

China Vesting researches 500 of the top U.S.-listed Chinese Public Companies and tracks the best 100 with state-of-the-art performance benchmarks. China Vesting is based in Dongguan, China, an industrial city located in the Pearl River Delta. Dongguan borders the provincial capital of Guangzhou to the north, Huizhou to the northeast, Shenzhen to the south, and the Pearl River to the west. Our network consists of Chinese officials, investment bankers, venture capitalists, scholars, academics and most importantly entrepreneurs that track China Stocks.

Posted in Press ReleasesComments (0)

Search Articles

Archives